Colorectal cancer "methylator phenotype": Fact or artifact?

Neoplasia

Volumn 7, Issue 4, 2005, Pages 331-335

  Anacleto, Charles ^a   Leopoldino, Andréia M ^a   Rossi, Benedito ^b   Soares, Fernando A ^b   Lopes, Ademar ^b   Rocha, José Cláudio C ^b   Caballero, Otávia ^c   Camargo, Anamaria A ^c   Simpson, Andrew J G ^c   Pena, Sérgio D J ^a  

^a FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^b A C CAMARGO CANCER CENTER   (Brazil)

^c LUDWIG INSTITUTE FOR CANCER RESEARCH   (Brazil)

Author keywords

Cancer; Colorectal; CpG methylation; Microsatellite instability; Phenotype

Indexed keywords

DEATH ASSOCIATED PROTEIN KINASE; METHYLATED DNA PROTEIN CYSTEINE METHYLTRANSFERASE; PROTEIN MLH1; PROTEIN P14ARF; PROTEIN P16INK4A;

ARTICLE; CANCER LOCALIZATION; CLINICAL FEATURE; COLON; COLORECTAL CANCER; CONTROLLED STUDY; CPG ISLAND; GENE LOCUS; HUMAN; HUMAN TISSUE; METHYLATION; MICROSATELLITE INSTABILITY; PHENOTYPE; PRIORITY JOURNAL; PROMOTER REGION;

EID: 20844453068     PISSN: 15228002     EISSN: None     Source Type: Journal    
DOI: 10.1593/neo.04502     Document Type: Article

References (33)

1. Ionov Y, Peinado MA, Malkhosyan S, Shibata D, and Perucho M (1993). Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis. Nature 363, 558-561.
2. Lynch HT and de la Chapelle A (2003). Hereditary colorectal cancer. N Engl J Med 348, 919-932.
3. Aaltonen LA, Peltomaki P, Leach FS, Sistonen P, Pylkkanen L, Mecklin JP, Jarvinen H, Powell SM, Jen J, and Hamilton SR (1993). Clues to the pathogenesis of familial colorectal. Science 260, 812-816.
4. Thibodeau SN, Bren G, and Schaid D (1993). Microsatellite instability in cancer of the proximal colon. Science 260, 816-819.
5. Ribic CM, Sargent DJ, Moore MJ, Thibodeau SN, French AJ, Goldberg RM, Hamilton SR, Laurent-Puig P, Gryfe R, Shepherd LE, et al. (2003). Tumor microsatellite-instability status as a predictor of benefit from fluorouracil-based adjuvant chemotherapy for colon cancer. N Engl J Med 349, 247-257.
6. Herman JG and Baylin SB (2003). Gene silencing in cancer in association with promoter hypermethylation. N Engl J Med 349, 2042-2054.
7. Bubb VJ, Curtis LJ, Cunningham C, Dunlop MG, Carothers AD, Morris RG, White S, Bird CC, and Wyllie AH (1996). Microsatellite instability and the role of hMSH2 in sporadic colorectal cancer. Oncogene 12, 2641-2649.
8. Aaltonen LA, Salovaara R, Kristo P, Canzian F, Hemminki A, Peltomaki P, Chadwick RB, Kaariainen H, Eskelinen M, Jarvinen H, et al. (1998). Incidence of hereditary nonpolyposis colorectal cancer and the feasibility of molecular screening for the disease. N Engl J Med 338, 1481-1487.
9. Senba S, Konishi F, Okamoto T, Kashiwagi H, Kanazawa K, Miyaki M, Konishi M, and Tsukamoto T (1998). Clinicopathologic and genetic features of nonfamilial colorectal carcinomas with DNA replication errors. Cancer 82, 279-285.
10. Kane MF, Loda M, Gaida GM, Lipman J, Mishra R, Goldman H, Jessup JM, and Kolodner R (1997). Methylation of the hMLH1 promoter correlates with lack of expression of hMLH1 in sporadic colon tumors and mismatch repair-defective human tumor cell lines. Cancer Res 57, 808-811.
11. Grady WM and Markowitz SD (2002). Genetic and epigenetic altera-tions in colon cancer. Annu Rev Genomics Hum Genet 3, 101-128.
12. Toyota M, Ahuja N, Ohe-Toyota M, Herman JG, Baylin SB, and Issa JP (1999). CpG island methylator phenotype in colorectal cancer. Proc Natl Acad Sci USA 96, 8681-8686.
13. Ahrendt SA, Chow JT, Xu LH, Yang SC, Eisenberger CF, Esteller M, Herman JG, Wu L, Decker PA, Jen J, et al. (1999). Molecular detection of tumor cells in bronchoalveolar lavage fluid from patients with early stage lung cancer. J Natl Cancer Inst 91, 332-339.
14. Herman JG, Graff JR, Myohanen S, Nelkin BD, and Baylin SB (1996). Methylation-specific PCR: a novel PCR assay for methylation status of CpG islands. Proc Natl Acad Sci USA 93, 9821-9826.
15. Katzenellenbogen RA, Baylin SB, and Herman JG (1999). Hypermethylation of the DAP-kinase CpG island is a common alteration in B-cell malignancies. Blood 93, 4347-4353.
16. 6-methylguanine-DNA methyltransferase by promoter hypermethylation is a common event in primary human neoplasia. Cancer Res 59, 793-797.
17. Esteller M, Tortola S, Toyota M, Capella G, Peinado MA, Baylin SB, and Herman JG (2000). Hypermethylation-associated inactivation of p14(ARF) is independent of p16(INK4a) methylation and p53 mutational status. Cancer Res 60, 129-133.
18. Boland CR, Thibodeau SN, Hamilton SR, Sidransky D, Eshleman JR, Burt RW, Meltzer SJ, Rodriguez-Bigas MA, Fodde R, Ranzani GN, et al. (1998). A National Cancer Institute Workshop on Microsatellite Instability for Cancer Detection and Familial Predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. Cancer Res 58, 5248-5257.
19. Rampino N, Yamamoto H, Ionov Y, Li Y, Sawai H, Reed JC, and Perucho M (1997), Somatic frameshift mutations in the BAXgene in colon cancers of the microsatellite mutator phenotype. Science 275, 967-969.
20. Hoang JM, Cottu PH, Thuille B, Salmon RJ, Thomas G, and Hamelin R (1997). BAT-26, an indicator of the replication error phenotype in colorectal cancers and cell lines. Cancer Res 57, 300-303.
21. Pena SDJ (1999). Single-tube single-colour multiplex PCR amplification of ten polymorphic microsatellites (ALF10): a new powerful tool for DNA profiling. Pure Appl Chem 71, 1683-1690.
22. Sokal RR and Rohlf FJ (1995). Biometry, 3rd ed, p. 887 W. H. Freeman and Co., New York.
23. Esteller M, Corn PG, Baylin SB, and Herman JG (2001). A gene hypermethylation profile of human cancer. Cancer Res 61, 3225-3229.
24. INK4a genes in colon cancer. Lab Invest 81, 217-229.
25. INK4a in some human primary tumors. Mutat Res 530, 9-17.
26. Ward RL, Cheong K, Ku SL, Meagher A, O'Connor T, and Hawkins NJ (2003). Adverse prognostic effect of methylation in colorectal cancer is reversed by microsatellite instability. J Clin Oncol 21, 3729-3736.
27. Yamashita K, Dai T, Dai Y, Yamamoto F, and Perucho M (2003). Genetics supersedes epigenetics in colon cancer phenotype. Cancer Cell 4, 121-131.
28. Toyota M, Ohe-Toyota M, Ahuja N, and Issa JP (2000). Distinct genetic profiles in colorectal tumors with or without the CpG island methylator phenotype. Proc Natl Acad Sci USA 97, 710-715.
29. Jemal A, Tiwari RC, Murray T, Ghafoor A, Samuels A, Ward E, Feuer EJ, Thun MJ, and American Cancer Society (2004). Cancer statistics, 2004. CA Cancer J Clin 54, 8-29.
30. de la Chapelle A (2003). Microsatellite instability. N Engl J Med 349, 209-210.
31. van Rijnsoever M, Grieu F, Elsaleh H, Joseph D, and lacopetta B (2002). Characterisation of colorectal cancers showing hypermethylation at multiple CpG islands. Gut 51, 797-802.
32. Whitehall VL, Wynter CV, Walsh MD, Simms LA, Purdie D, Pandeya N, Young J, Meltzer SJ, Leggett BA, and Jass JR (2002). Morphological and molecular heterogeneity within nonmicrosatellite instability high colorectal cancer. Cancer Res 62, 6011-6014.
33. Hawkins N, Norrie M, Cheong K, Mokany E, Ku SL, Meagher A, O'Connor T, and Ward R (2002). CpG island methylation in sporadic colorectal cancers and its relationship to microsatellite instability. Gastroenterology 122, 1376-1387.